ABCL — AbCellera Biologics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for AbCellera Biologics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	595	723	886	761	626
Net Total Accounts Receivable
Net Total Receivables	212	175	103	64.4	92.1
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	813	930	1,025	872	751
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	17.9	112	217	288	340
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	1,006	1,319	1,541	1,488	1,361
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	103	121	118	119	76.6
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	175	293	308	336	304
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	831	1,026	1,233	1,152	1,056
Total Liabilities & Shareholders' Equity	1,006	1,319	1,541	1,488	1,361
Total Common Shares Outstanding